We present a protocol for using the triple malignant brain tumor domains of l3MBtl1 (3xMBt), which bind to mono-and di-methylated lysine with minimal sequence specificity, in order to enrich for such methylated lysine from cell lysates. cells in culture are grown with amino acids containing light or heavy stable isotopic labels. Methylated proteins are enriched by incubating cell lysates with 3xMBt, or with the binding-null D355n mutant as a negative control. Quantitative liquid chromatography and tandem mass spectrometry (lc-Ms/Ms) are then used to identify proteins that are specifically enriched by 3xMBt pull-down. the addition of a third isotopic label allows the comparison of protein lysine methylation between different biological conditions. unlike most approaches, our strategy does not require a prior hypothesis of candidate methylated proteins, and it recognizes a wider range of methylated proteins than any available method using antibodies. cells are prepared by growing in isotopic labeling medium for about 7 d; the process of enriching methylated proteins takes 3 d and analysis by lc-Ms/Ms takes another 1-2 d.
IntroDuctIon
Recent work has shown that a wide range of nonhistone proteins are modified by the addition of up to three methyl groups to the ε-nitrogen of lysine side chains [1] [2] [3] [4] . Proteome-wide enrichment of specific post-translational modifications (PTMs) has been used to map the extent of other PTMs, including phosphorylation, acetylation and ubiquitylation. In most cases, these procedures are based on pan-specific enrichment using antibodies or chemical affinity [5] [6] [7] . However, applying similar approaches to methylated lysine has proven to be challenging. We recently demonstrated an approach that uses a naturally occurring methyl-lysine binding domain as a tool for enrichment and identification of proteins modified by lysine methylation 2 . The triple malignant brain tumor domains (3xMBT) of the protein L3MBTL1 bind to mono-and di-methylated lysine with minimal sequence specificity. Expressing 3xMBT as a fusion with glutathione S-transferase (GST) allows 3xMBT to be anchored to beads functionalized with reduced glutathione (GSH), thereby providing a generalized tool for enriching lysine methylation that is inexpensive and reproducible ( Fig. 1) . Proteins enriched by 3xMBT from cell lysate can be analyzed by western blotting or by separation on SDS-PAGE, followed by in-gel digestion with trypsin and LC-MS/MS.
Protein pull-downs from cell lysate are generally contaminated by residual abundant proteins and proteins bound through nonspecific interactions to the beads, to GST or to 3xMBT. A point mutation that specifically abrogates methyl-lysine recognition, D355N, provides a negative control for nonspecific binding (3xMBT D355N ) 8, 9 . To separate candidate methylated proteins from background signals, we incorporate stable isotopic labeling in cell culture (SILAC) 10 . This allows a direct quantitative comparison between proteins bound by 3xMBT and proteins bound by the 3xMBT D355N negative control (Fig. 1b) . Strong enrichment (e.g., more than twofold) by 3xMBT indicates a candidate methylated protein. The SILAC approach can be extended to three quantitative channels, allowing simultaneous quantitative comparison among two biological conditions and the negative control (Fig. 1c) .
Applications of methyl-lysine protein enrichment
The protocol enables the identification of methylated proteins and quantitative comparison of methylation between different biological conditions in cell culture. It is applicable to any biological system that can be prepared in culture with amino acids containing defined light and heavy stable isotopes. Alternative experimental designs such as 'super SILAC' may enable analysis of biological systems that are not amenable to labeling with heavy amino acids 11 .
The use of SILAC allows small differences in protein methylation to be measured accurately and reproducibly between different conditions. Technical and biological variations depend on protein abundance, repeatability of the biological system and the number of peptides identified during LC-MS/MS analysis. We have used this approach to identify candidate substrates of the lysine methyltransferases G9a and GLP by examining changes after treatment of cells with the small-molecule inhibitor UNC0638 (refs. 2,12) . We have also applied this approach to yeast after knockout of the methyltransferase Rkm1, and we observed reduced methylation of its known substrate Rpl23 (ref. 13 ) (see ANTICIPATED RESULTS). The same methodology could be applied to examine methylation dynamics during temporal processes such as the cell cycle, or after treatment with biologically active molecules such as growth factors.
This protocol makes use of the 3xMBT domain of L3MBTL1, because it has pan-specific affinity for mono-and di-methylated lysine 2, 8 . Many other protein domains bind specifically to methylated lysine with varying degrees of target specificity. A variation on this approach may be used to identify methylation-specific interactions for these domains by using them in place of the 3xMBT domain 4 . Such a procedure could begin by identifying a point mutation that disrupts the methyl-lysine-binding pocket. Proteins bound by the wild-type and inactive domains can then be compared and candidate methyl-specific interactions can be selected for further validation.
Comparison with other methods
Pan-specific antibodies have been used for proteomic analysis of other PTMs [5] [6] [7] . Unfortunately, commercially available panmethyl antibodies have shown high nonmethyl-specific binding and preference for particular sequences, and they are therefore not suitable for pan-methyl enrichment 14 . Coupling enrichment of methylated proteins with a pan-methyl antibody with heavy methyl SILAC has been used to identify some methylation events, but the pan-methyl antibodies were found to contribute little in terms of methyl-specific enrichment 15, 16 . Other research groups have generated their own polyclonal antibodies to conduct methyl-peptide enrichment, and they have succeeded in enriching methylated peptides 3 . The variable nature of polyclonal antibodies makes it difficult to use this approach as a consistent tool. Another recent publication identified methylated proteins from the interactome of the chromodomain of HP1β, but this affinity enrichment is presumably limited to proteins bearing an appropriate recognition sequence 4 .
Experimental design
This method is used for performing quantitative comparisons between pull-downs by 3xMBT and 3xMBTD 355N . This is achieved by using SILAC-the differential labeling of cells in culture with amino acids, usually arginine and lysine, containing specific stable isotopes. There are many amino acids and isotopic labels that may be used depending on the needs of a particular experiment. We perform two-way experiments using normal amino acids for one culture condition (light) and 2 H 4 -l-lysine/ 13 C 6 -l-arginine (medium) or 15 N 2 13 C 6 -l-lysine/ 15 N 4 13 C 6 -l-arginine (heavy) for the other. This design is suitable for comparing 3xMBT with 3xMBT D355N under a single biological condition. For a threeway comparison, we culture cells in light, medium and heavy media. This design is suitable for comparing 3xMBT pull-down between two experimental conditions along with one pull-down using 3xMBT D355N as a negative control.
In a three-way experiment, the protein sample for the 3xMBT D355N pull-down should be prepared by using the condition that is expected to have the most lysine methylation (e.g., overexpression of a lysine methyltransferase (KMT), or the absence of a KMT inhibitor). If there is no a priori expectation about the amount of methylation, then we alternate the condition used for the negative control. We use the medium SILAC condition for the 3xMBT D355N pull-down because it is possible for strong signals in the medium channel to carry into the heavy Proteins modified by lysine mono-or di-methylation are selectively bound by the GST-3xMBT fusion protein immobilized on beads. The fusion protein and any bound proteins are eluted with reduced glutathione, the glutathione is removed and GST-3xMBT is depleted by rebinding to beads while using high salt to disrupt 3xMBT binding to methylated proteins. (b) SILAC for identifying candidate methylated proteins. Protein extracts are prepared from cells grown in medium containing amino acids with either light or medium stable isotopes. The two samples are incubated with 3xMBT or the 3xMBT D355N negative control, bound proteins are combined and proteins enriched by 3xMBT are identified by quantitative LC-MS/MS. (c) Experimental design to compare methylation states between two biological conditions. Cells are prepared in light or heavy amino acids under the treatment conditions being compared. The two sets of cells are combined before lysis. The medium amino acids are again used to distinguish the 3xMBT D355N negative control. (d,e) Mass spectra from an experiment using human cell lysate and the experimental design from panel b. SILAC data for a peptide from a known methylated protein, the lysine methyltransferase G9a, is shown in d, whereas e shows a protein that appears to be nonspecifically bound by 3xMBT and 3xMBT D355N . The asterisk (*) indicates light and heavy forms of the peptide, with the low m/z peak representing 3xMBT D355N pull-down and the high m/z peak the 3xMBT pull-down.
channel. As the 3xMBT D355N pull-down has the lowest expected signal, this design minimizes carryover. Other SILAC conditions and amino acids may be used, depending on the needs of a particular experiment 10, 17 . As information regarding the source of a given peptide is encoded in the isotopic label, samples from different labeling conditions should be combined as early as possible to minimize variability during preparation (i.e., before cell lysis, for samples that will both be used for 3xMBT pull-down) and after the pull-down (Step 20) for samples from pull-downs with different domains (e.g., 3xMBT and 3xMBT D355N ).
We perform all experiments in duplicate with the biological conditions reversed between light and heavy SILAC labels. This label swap allows contaminant signals to be easily eliminated (e.g., ambient proteins such as keratins will be found in the light channel in both experiments). Additional replicates are necessary if the goal is the statistical analysis of differential protein pull-down.
Identification of methylated proteins depends on the depth of coverage achieved during LC-MS/MS. The number of proteins identified can often be increased by dividing each sample into several molecular-weight fractions after SDS-PAGE (Steps 27 and 28), or by adjusting the length of the HPLC gradient used during LC-MS/MS. We generally divide proteins from human cells into five molecular-weight fractions and analyze each with a 2-h gradient. Similarly, we divide protein from yeast cells into three fractions, also analyzed over 2-h gradients. Subcellular fractionation can also be used to further enrich for proteins targeted by a specific methyltransferase. For example, nuclear extracts can be used for pull-down experiments to identify targets of a nuclear methyltransferase, thereby limiting nonspecific signals from cytosolic proteins. It is also possible that some proteins enriched by 3xMBT are not methylated themselves but are enriched as part of a complex with at least one methylated subunit. We routinely validate candidate methylated proteins by immunoprecipitation from cells; this is followed by comprehensive analysis using LC-MS/MS to map modified residues. We also validate candidate methyltransferase substrates by in vitro methylation assays.
For the LC-MS/MS analysis, we recommend HPLC gradients between 2 and 4 h with reverse-phase chromatography on a C18 resin, the use of an electrospray tip flowing no faster than 200 nl min −1 and a mass spectrometer running in data-dependent acquisition mode with capabilities similar to or better than an LTQ Orbitrap XL. We have used Thermo Scientific Q-Exactive, LTQ Orbitrap Elite and Velos instruments. MS1 scans are performed at high resolution in the Orbitrap mass analyzer, followed by MS/MS scans on the top ten peptides with dynamic exclusion. We find similar results by performing MS/MS with collision-induced dissociation (CID) or higher-energy collisional dissociation (HCD) fragmentation, and with MS/MS spectra collected using either ion trap or Orbitrap mass analyzers.
Limitations of the method
The quantitative readout of this protocol represents a bulk measurement of the methylation status of a protein; it does not distinguish among methylation of individual lysine residues within a protein or determine stoichiometry of methylation at any particular site. For example, the methyltransferase G9a mono-and di-methylates histone H3 at lysine 9 in vivo 18 , but inhibiting G9a only reduces the methyl-dependent pull-down of H3 by 3xMBT by ~10% (ref. 2) , almost certainly because H3 is modified at multiple lysines by many methyltransferases 19 . In addition, the 3xMBT domain does not recognize tri-methylated lysine, nor can it distinguish between mono-and di-methylation. Therefore, methylation states that change between mono-and di-methyl, and changes in the amount of tri-methylation that do not alter mono-or di-methylation, will not be observed using this protocol.
Although knowing that a protein is methylated is helpful, addressing specific biological questions often requires the determination of the particular site of methylation. One limitation of the 3xMBT approach is that specific methylated residue(s) are not identified from every enriched protein. This is because analysis by LC-MS/MS only identifies a subset of peptides from each protein. This is especially true for proteins that are large, expressed in low abundance or methylated with low stoichiometry. In other cases, the methylated residue may occur in a sequence context that is digested by trypsin into peptides that are either too short or too long for identification by LC-MS/MS. Protein sequence coverage may be improved by performing additional fractionation at the protein or peptide levels or by using alternative proteases such as chymotrypsin or Glu-C 20 .
Proteomic strategies for detecting other PTMs, such as phosphorylation and acetylation, identify modified residues directly by conducting the affinity enrichment on peptides produced by tryptic digest, so that modified peptides are enriched directly without coenrichment of unmodified peptides from the same proteins 5 . We have been unable to efficiently enrich peptides from digested cellular extracts with 3xMBT 2 . This may be an area for future development of the 3xMBT domain and related approaches.
MaterIals

REAGENTS
Plasmids: 3xMBT-pGEX6P-1 and 3xMBT D355N -pGEX6P- 15 N 2 13 C 6 -l-lysine2HCl (Thermo Scientific/Pierce, cat. no. 88209), 15 N 4 13 C 6 -l-arginine-HCl (Thermo Scientific/Pierce, cat. no. 89990), l-proline (Thermo Scientific/ Pierce, cat. no. 88430) Yeast strain from any background (for example, Fisher cat. no. NC0537738), but they must be auxotrophic for arginine and lysine (arg4 lys2) as described in ref. 21 21 for the preparation of yeast growth medium. We recommend verifying complete incorporation of the SILAC label in your particular cellular system 10 . Protein sample from mammalian cell culture Split the cell type of interest into each SILAC medium and grow it in culture for at least seven population doublings before performing treatments or cell lysis 22 . We recommend preparing the entire experiment in duplicate with light and medium labels swapped (in a two-way SILAC), or light and heavy labels swapped and the medium label duplicated (in a three-way SILAC). Any procedure may be used for protein extraction, but the pH should be ~7.4 with 50-100 mM buffer (Tris in this protocol), salt concentration should be ~150 mM (NaCl in this protocol) and the sample should contain 0.05-0.1% (vol/vol) nonionic detergent such as NP-40 or TritonX-100 (SDS is not recommended) 2 . If you are using three-way SILAC, then the light and heavy cells should be combined immediately before lysis (referred to as light + heavy, and heavy + light samples to represent the label swap), whereas the medium lysate is processed separately until the high-salt dialysis (Step 20). Each sample volume should be 0.5-1 ml and should contain between 600 µg and 5 mg of protein.
To account for small differences in protein levels, a small aliquot of each protein sample is removed immediately before starting the 3xMBT pulldown and used to calculate a correction factor for protein loading (Step 13). Protein sample from yeast extract Yeast strains must be auxotrophic for arginine and lysine to prevent biosynthesis of unlabeled amino acids (arg4 lys2) 21 . Grow yeast in 5 ml of each SILAC medium overnight at 30 °C. Dilute each culture to OD 600 = 0.2 in 50 ml of SILAC medium and grow it to OD 600 = 0.6-1.0 at 30 °C. Pellet the cells, by combining equivalent cell numbers of light and heavy cultures if you are using three-way SILAC. Wash the cells once in 5 ml of lysis/binding buffer and resuspend them in 1 ml of lysis/binding buffer supplemented with 0.5 mM PMSF and 2 µl of yeast protease inhibitor cocktail. Bead-beat the yeast in a 1.5-ml microcentrifuge tube by using glass beads, and then vortex the tube for 15 min at 4 °C. Transfer the lysates to a fresh tube and pellet the debris at 20,000g for 15 min at 4 °C. NaCl, 5 M Add 292.2 g of NaCl to a graduated cylinder and add deionized water to a final volume of 1 liter. Place the solution in a large beaker and mix it by using a magnetic stir rod until the NaCl is fully dissolved. Store it at room temperature (20 °C) for 6 months. Tris, 1 M, pH 7.4 Add 121.1 g of Tris base to a graduated cylinder and add deionized water to 900 ml. Place the solution in a large beaker and mix it with a magnetic stir rod. Add HCl while monitoring the pH with a pH meter until the pH reaches 7.4 (this will probably require 60-65 ml of HCl). Once the pH is reached and Tris is dissolved, return the solution to the graduated cylinder and adjust the final volume to 1 liter by using deionized water. Store it at room temperature for 6 months. Tris, 1 M, pH 8.0 Prepare this the same way as 1 M Tris (pH 7.4), but instead adjust the pH to 8.0 (this will probably require 40-45 ml of HCl). Store it at room temperature for 6 months. Lysis/binding buffer Lysis/binding buffer contains 150 mM NaCl, 50 mM Tris HCl (pH 7.4), and 0.05% (vol/vol) NP-40. Combine 920 ml of deionized water, 50 ml of 1 M Tris (pH 7.4), 30 ml of 5 M NaCl and 0.5 ml of NP-40. Mix thoroughly at room temperature until the detergent is fully dissolved. Store the buffer at 4 °C for 6 months. IPTG, 1 M Place 715 mg of IPTG in a graduated cylinder and add deionized water to 3 ml. Vortex the mixture until IPTG is fully dissolved. Store IPTG at −20 °C for 6 months. Ampicillin, 50 mg ml −1 Dissolve 50 mg of ampicillin in 1 ml of deionized water. Store it at −20 °C for 6 months. Lysozyme, 50 mg ml −1 Dissolve 50 mg of lysozyme in 1 ml of deionized water. Store it at −20 °C for 6 months. Urea, 8 M Place 0.48 g of urea in a graduated cylinder and add deionized water to 1 ml. Vortex the mixture until urea is fully dissolved. Store it at room temperature for 1 week. DTT, 1 M Place 154 mg of DTT in a graduated cylinder and add deionized water to 1 ml. Vortex the mixture until DTT is fully dissolved. Store it at −20 °C for 6 months. Iodoacetamide, 10 mg ml −1 Dissolve 10 mg of iodoacetamide in 1 ml of deionized water. Prepare the solution immediately before use. Formic acid, 10% (vol/vol) Measure 10 ml of concentrated formic acid by using a glass graduated cylinder and glass pipettes, and then add this to 90 ml of deionized water. Store it at room temperature in a glass bottle for 3 months. Elution buffer Elution buffer contains 100 mM Tris HCl (pH 8.0) and 10 mg ml −1 reduced glutathione. Combine 885 µl of deionized water, 100 µl of 1 M Tris (pH 8.0), 10 mg of glutathione and 15 µl of 1N NaOH. Prepare the buffer on the day of use. High-salt dialysis buffer High-salt dialysis buffer contains 750 mM NaCl and 50 mM Tris (pH 7.4). Combine 1.6. liters of deionized water with 300 ml of 5 M NaCl and 100 ml of 1 M Tris (pH 7.4). Store the buffer at 4 °C for 6 months. Digest buffer Digest buffer is 50 mM ammonium bicarbonate. Dissolve 395 mg of ammonium bicarbonate in 100 ml of deionized water. Store the buffer in a glass container for up to 6 months. Acidifying buffer Combine 450 µl of deionized water, 50 µl of formic acid and 500 µl of acetonitrile. Mix the buffer in a plastic tube and use it immediately or store it in a glass container for up to 1 month. proceDure prepare 3xMBt beads • tIMInG 4 d 1| Add 1 ng each of 3xMBT-pGEX6p-1 and 3xMBT D355N -pGEX6p-1 plasmid to separate 10-µl aliquots of competent BL21 E. coli cells, incubate them on ice for 5 min, transfer them to a heat block at 42 °C for 45 s and transfer them back onto ice for 2 min. These two cultures are processed in parallel to (and including) Step 12.
2| Add the transformed bacteria to 3 ml of LB medium with 50 µg ml −1 ampicillin. Grow this starter culture at 37 °C with shaking at 220 r.p.m. overnight.
3| Dilute 1 ml of the starter culture into 100 ml of LB medium at room temperature with 50 µg ml −1 ampicillin (this culture can be scaled up to 0.5 liters as needed, maintaining the 1-100 ratio of starter culture to final culture volume). Grow the culture at 37 °C with shaking at 220 r.p.m. for 2.5 h.
4| Add 10 µl of 1 M IPTG per 100 ml of culture (final concentration 100 µM) to induce protein expression. Grow the culture at 20 °C overnight with shaking at 220 r.p.m.
5|
Pellet the bacteria by centrifugation at 6,000g for 10 min at 4 °C. Pour off the medium. ! cautIon Liquid nitrogen is cryogenic and should be used in a well-ventilated space.  pause poInt The bacterial pellet may be flash-frozen by immersing the tube in liquid nitrogen, and it can be stored at −80 °C for 3 months.
6|
On ice, resuspend the pellets in lysis/binding buffer supplemented with 1 mM PMSF and protease inhibitor cocktail (one tablet per 50 ml of buffer). Use 10 ml of lysis/binding buffer for every 100 ml of bacterial culture volume pelleted. 
10|
While you are waiting for the spin in Step 9, prewash the GSH-Sepharose beads three times by adding 10 ml of lysis/ binding buffer, pelleting the beads by spinning at 1,000g for 2 min at 4 °C and removing the buffer. Use 100 µl of GSHSepharose per 50 ml of original bacterial culture volume.
11|
Pour the cleared lysate from Step 9 onto the washed GSH-Sepharose beads and rotate the tube on the rotisserie at 4 °C overnight.
12| Pellet the beads by spinning them at 500g for 2 min at 4 °C. Carefully aspirate and discard the supernatant. Wash the beads three times by adding 10 ml of lysis/binding buffer on ice, rotating them on the rotisserie at 4 °C for 5 min and pelleting them as before. After aspirating the third wash, add 820 µl of lysis/binding buffer per 100 µl of original GSH-Sepharose volume (Step 10) and keep it on ice or at 4 °C until Step 14. We recommend preparing beads to be used the same day. ? trouBlesHootInG 3xMBt pull-down • tIMInG 2 d 13| Remove an aliquot of each protein sample (Reagent Setup) to use for normalization of protein loading (input samples,
Step 41). For protein samples from a two-way SILAC, follow option A (Fig. 1b) ; for samples from a three-way SILAC, follow option B (Fig. 1c) 14| Set up 3xMBT and 3xMBT D355N pull-downs, depending on whether the experiment uses two-or three-way SILAC. For a two-way SILAC, follow option A; for a three-way SILAC follow option B. 
15|
Incubate the pull-down samples rotating on the rotisserie overnight at 4 °C.
16|
Pellet the beads at 1,500g for 2 min at 4 °C and carefully remove the supernatant. Wash the beads four times by adding 750 µl of binding buffer, rotating the beads on a rotisserie at 4 °C for 5 min, pelleting at 1,500g for 2 min at 4 °C and removing the supernatant.
17|
After the final wash, remove all excess liquid, being careful not to remove any beads. For proteomic analysis, continue immediately to Step 18. Samples may be analyzed by western blotting by adding Laemmli sample buffer directly to the beads and heating the beads between 95 and 100 °C for 5 min. Samples for western blotting may be stored at 4 °C for 1 week or at −20 °C indefinitely.  crItIcal step Residual buffer from the GSH-Sepharose beads will increase the volume of the sample and make it difficult to load for SDS-PAGE. 
21|
Transfer each combined eluate into a Slide-A-Lyzer mini dialysis tube. Place the tube in a floating tube holder and dialyze the contents overnight at 4 °C against 2 liters of high-salt dialysis buffer, stirring the buffer on a magnetic stirrer.  crItIcal step Position the dialysis tube so that the liquid level inside the tube is higher than that of the buffer outside the tube. This prevents the sample volume from increasing as the two levels equalize.  crItIcal step Overnight dialysis is necessary to remove enough free glutathione so that 3xMBT can be depleted by rebinding to fresh GSH-Sepharose beads.
22|
Prewash 150 µl of GSH-Sepharose beads for each pull-down by adding 1 ml of lysis/binding buffer, pelleting the beads by spinning at 1,000g for 2 min at 4 °C and removing the buffer (wash three times total). Carefully remove all extra liquid after the last wash to minimize the volume added to the sample in Step 23.  crItIcal step The amount of GSH-Sepharose beads must be at least 1.5 times the amount of beads used in the pull-down in order to ensure sufficient depletion of the 3xMBT domain. This amount takes into consideration the total volume of beads represented by the eluates combined in Step 20.  crItIcal step Residual buffer from the GSH-Sepharose beads will increase the volume of the sample and make it difficult to load for SDS-PAGE.
23| Add the dialyzed eluate from
Step 21 to the prewashed GSH-Sepharose to rebind the 3xMBT. Rotate the mixture on the rotisserie at 4 °C for 4 h.
24|
Pellet the GSH-Sepharose, which has bound most of the 3xMBT domain, by spinning it at 1,500g for 2 min at 4 °C. The domain should be depleted by >90%. Excess 3xMBT can distort the SDS-PAGE gel in later steps (Fig. 2a,b) .
25|
Transfer each supernatant to a fresh 1.5-ml tube. Spin the supernatant once more at maximum speed for 5 min at 4 °C to ensure that all beads are removed.  crItIcal step Use a gel-loading micropipette tip to remove as much liquid as possible from the packed beads; leaving behind any sample will reduce the protein yield.
26|
Transfer the supernatant containing methylated proteins to a new tube and add 4× Laemmli buffer. Incubate the samples at 95-100 °C for 5 min.  pause poInt After heating, the samples may be stored at −20 °C for up to 2 weeks. Heat the frozen samples as in Step 26 before continuing. 
27|
Run the samples on an SDS-PAGE gel. Load the samples into the fewest possible lanes to minimize the gel volume used and separate the samples from label-swap experiments by at least one lane containing only Laemmli buffer. To ensure that even low-molecular-weight proteins are retained, the dye front should not be run off the gel. ? trouBlesHootInG 28| Stain the gel according to the directions in the silver staining kit.  crItIcal step From this point forward, keep the gel covered during all incubation steps to minimize contamination from proteins in the air.  crItIcal step A dedicated container should be used for silver staining; it should never have been exposed to any type of protein or blocking buffer, such as milk or BSA.
? trouBlesHootInG 29| Use a clean razor blade to remove and discard the band corresponding to the remaining 3xMBT in the sample (Fig. 2c) . Use a fresh razor blade for each label-swap experiment to prevent cross-contamination. Cut each sample into the desired number of molecular-weight fractions (Fig. 2c) . The use of more fractions increases proteomic coverage but also increases the mass spectrometry time required.
30|
Dice each fraction into small pieces (~1 mm 3 ). All lanes containing the same label can be cut together.
31|
Transfer the gel pieces from each fraction into a 1.5-ml tube and destain the gel pieces according to the instructions for the silver staining kit.
32|
Wash the gel pieces for 5 min with 1 ml of digest buffer.  crItIcal step When you are changing solutions, remove as much liquid as possible.
33|
Replace the buffer with 1 ml of digest buffer supplemented with 10 mM DTT. Incubate the gel pieces at 55-65 °C for 1 h.
34|
Wash the gel pieces for 5 min in 1 ml of digest buffer.
35|
Replace the buffer on the gel pieces with digest buffer supplemented with 10 mg ml −1 iodoacetamide. Incubate the gel pieces at room temperature in darkness for 1 h.  crItIcal step Prepare iodoacetamide solution immediately before use.
36|
Remove the iodoacetamide from the gel pieces and wash them in 1 ml of acetonitrile for 5 min with shaking or rotation. The gel pieces will dehydrate, becoming off-white or yellow. Remove the acetonitrile and wash the pieces again for 5 min with fresh acetonitrile.  crItIcal step Gel pieces must dehydrate completely for trypsin to be efficiently absorbed in Step 38. Repeat
Step 36 if the gel pieces are not uniformly opaque.
37|
Use the SpeedVac to dry the gel pieces for 15 min.
38|
Remove the dehydrated gel pieces from the SpeedVac and place them on ice. Cover the gel pieces in digest buffer with 12.5 ng µl −1 trypsin (31 µl of trypsin per ml of digest buffer) and incubate them on ice for 30 min.
39|
Remove any remaining trypsin buffer from the gel pieces and cover them in a minimal volume of digest buffer.
40|
Leave the gel pieces overnight at room temperature in darkness to complete digestion.
Digest the input samples • tIMInG 2 d  crItIcal Perform Steps 41-45 in parallel with
Steps 33-40.
41| Add 2 µl of digest buffer supplemented with 100 mM DTT to each input sample from Step 13. Incubate the input samples at 55-65 °C for 1 h.
42| Add 2 µl of digest buffer supplemented with 100 mg ml −1 iodoacetamide to each input sample. Incubate the samples at room temperature in darkness for 1 h.
43|
Add 80 µl of digest buffer to each input sample.
44| Add 3 µl of trypsin to each input sample (to reach about 12.5 ng µl −1 ) and incubate the samples overnight in darkness at room temperature.
45| Add 10 µl of 10% (vol/vol) formic acid to each input sample to stop the digestion.  pause poInt Digested input samples may be stored at 4 °C for 1 week or at −20 °C for 1 month.
extract peptides from the in-gel digest • tIMInG 6 h 46| Prepare a 1.5-or 15-ml tube to collect peptides from each of the digested fractions.
47|
Transfer the digest buffer from each gel fraction into its respective collection tube. From this point, pool all subsequent washes and extracts into the same respective tubes.
48|
Wash the gel pieces with a minimal volume (to cover the gel pieces) of acidifying buffer for 5 min. Transfer the buffer to the collection tubes.
49|
Dehydrate the gel pieces with 600 µl of acetonitrile for 5 min with rotation or shaking. Transfer the acetonitrile to the appropriate collection tubes.  crItIcal step Gel pieces must be completely dehydrated to ensure maximum peptide recovery. Repeat
Step 49 if the gel pieces are not uniformly opaque.
50|
Rehydrate the gel pieces with a minimal volume of digest buffer.
51| Pool residual digest buffer into the collection tubes and repeat the dehydration in
Step 49.
52|
Dry down the pooled fractions in the collection tubes with a SpeedVac. It may be helpful to divide the sample among several tubes to increase the drying rate.  pause poInt Dried peptides may be stored at 4 °C for 1 week or at −20 °C for 1 month.
lc-Ms/Ms
• tIMInG 2-24 h 53| Analyze each fraction collected in Step 52 separately, as well as 10% of the digested input material (collected in Step 45) to be used in normalizing for protein loading. See the Experimental design section for more information. Analysis of proteins from in-gel digestion is routine for most mass spectrometry facilities, but the sample preparation and procedure for LC-MS/MS analysis depends on the configuration of the mass spectrometer and liquid chromatography system. We remove salts using C18 Stage Tips and analyze each fraction by using a 2-h reverse-phase HPLC gradient with 100 nl min −1 flow into an LTQ Orbitrap Velos. Each MS1 survey scan in the Orbitrap is followed by ten data-dependent MS/MS scans in the ion trap using CID fragmentation.
? trouBlesHootInG lc-Ms/Ms data analysis • tIMInG 2-8 h 54| Analyze LC-MS/MS data with one of the various software tools developed to identify and quantify peptides from LC-MS/MS data (for example, MaxQuant, MASCOT, Sequest) [23] [24] [25] . Search parameters should include variable modification of lysine with mono-, di-and tri-methylation (addition of 14.01565, 28.03130 and 42.04695 Da, respectively). We recommend consulting with a mass spectrometry core facility or laboratory regarding the analysis of your specific data set. MaxQuant 23 is a publically available tool for peptide identification that includes built-in support for protein quantification by SILAC. Any analysis should produce a spreadsheet of proteins identified and their light/medium and light/heavy SILAC ratios. Contaminant proteins such as keratin should be identified and excluded at this step (many software tools can flag these proteins automatically). Identification of methylated peptides should be carefully validated because they are subject to more frequent false identification than unmodified peptides or peptides carrying other common modifications such as phosphorylation (Box 1). ? trouBlesHootInG
55|
To normalize for differences in protein loading, calculate the median value of light/medium and light/heavy SILAC ratios for proteins identified in the input material (Step 45). Divide SILAC ratios for proteins identified in the pull-down by the median values from the input material.
? trouBlesHootInG Troubleshooting advice can be found in table 1. 
Box 1 | Identification and validation of methylated peptides by LC-MS/MS
Methylation is a challenging modification to identify by mass spectrometry, because the mass shift of 14 Da mimics the mass difference between many amino acids (e.g., glycine and alanine, serine and threonine). We routinely observe much higher incidence of false positives than is predicted by searching against a reverse sequence database. In particular, automated analysis is likely to misidentify related peptide sequences that differ by a single methyl group. These hits often have excellent scores for both peptide identification and position of the modification. It is therefore crucial that someone experienced with interpretation of mass spectra manually inspects any candidate methylated peptides. We apply two validation criteria that are specific for methylated peptides when confirming modification sites identified by high-throughput proteomics 2 : 1. Diagnostic fragment ions constrain the position of the methyl group to a single amino acid. It is standard practice to require that a modification be constrained to a specific residue, but methylation differs from other modifications because any amino acid should be considered a potential site of methylation if it could be exchanged for another amino acid by the addition of a methyl group (e.g., glycine, serine, etc.).
2. There are no nonmethylated peptides in the relevant proteome with the same mass and a similar peptide sequence. For example, tryptic peptides from closely related proteins such as human TOP2A and TOP2B differ by a single methyl group adjacent to the terminal lysine. In this example, a nonmethylated peptide from TOP2B is frequently misidentified as a methylated peptide from TOP2A: GFQQISFVNSIATSK*(TOP2A amino acids 307-319, * indicates methylation) GFQQISFVNSIATTK (TOP2B amino acids 328-342) A strategy to simplify the identification of methylated residues uses cells grown with heavy methionine to change the mass shift of the PTM 15 . In this approach, cells are grown in medium containing 2 H 3 13 C-methionine. Methionine is the precursor for biosynthesis of S-adenosyl methionine, the methyl-donating cofactor for protein methylation, and thus methylated residues gain 18 Da instead of 14 Da. This gives methylated peptides a unique mass shift that is unlikely to be mistaken for similar nonmethylated sequences. antIcIpateD results A single LC-MS/MS analysis from human cells in culture will identify several hundred to almost a thousand proteins depending on the amount of starting material, the cell line, the number of separate fractions produced before LC-MS/MS and the length of the HPLC gradients. Analysis of proteins from yeast will identify up to several hundred enriched proteins. We often eliminate proteins from the data set that are represented by only a single peptide. We also exclude from the data set any proteins that were observed in only one of the two label-swap experiments and any known contaminants (i.e., keratins, L3MBTL1 and trypsin).
Identification of candidate methylated proteins from quantitative pull-down data
In experiments with human material, at least 60% of proteins should be at least twice as abundant in 3xMBT pull-down compared with 3xMBT D355N pull-down. This threshold for candidate methylated proteins is set to exclude almost the entire range of natural variability among biological replicates, but some proteins with lower enrichment are also methylated 2 .
A pair of label-swap experiments can be easily visualized by placing proteins on a scatterplot according to their 3xMBT over 3xMBT D355N ratios in each experiment (Fig. 3a) . It is helpful to log-transform the ratios such that proteins that do not change between conditions cluster at the origin. Before plotting pull-down ratios, we normalize for protein loading by dividing each SILAC ratio from the 3xMBT pull-down by the median value of the same SILAC ratio in the input samples (
Step 55); this accounts for differences in the amount of protein originating from each cell lysate. In an experiment analyzing proteins captured by 3xMBT from yeast lysate, the most strongly enriched proteins include well-known methylated species such as histones H3 and H4, elongation factors EF1a and EF2 and ribosomal proteins including Rpl23 (Fig. 3a) .
Determination of differential methylation from quantitative data
To identify proteins that may be differentially methylated between two biological conditions, we first consider only proteins that are enriched by 3xMBT relative to 3xMBT D355N . Proteins that change between biological conditions but are not enriched by 3xMBT are likely to be differentially expressed, not methylated, and bound nonspecifically in the pull-down. Second, we consider whether the amount of protein bound by 3xMBT changes reproducibly in both experiments with labels swapped. The size of effect depends on several factors, especially the number of methylated residues on a protein. For example, human histone H3 can be methylated at a number of residues (major sites include K4, K9, K27, K36 and K79), and thus treatment with an inhibitor that blocks methylation of a specific residue results in only a small change in the amount of H3 captured by 3xMBT. Our experience indicates that knockdown, inhibition or overexpression of a methyltransferase often results in a 50% change in capture of known substrates of that enzyme 2 . As an example of how to identify candidate KMT substrates by 3xMBT pull-down and quantitative LC-MS/MS, we conducted a three-way SILAC experiment comparing lysine-methylated yeast proteins from wild-type and rkm1∆ strains 21 . Rkm1 is a KMT known to methylate the ribosomal protein Rpl23 (ref. 13) . In the experiment, we used wild-type and rkm1∆ strains grown in light or heavy SILAC medium, and the experiment was conducted as two replicates with light and heavy labels swapped between experiments. In each experiment, the medium SILAC condition contains 3xMBT D355N pull-down from wild-type cells. A complete list of proteins identified in both labeling directions and their quantitative data is shown in supplementary table 1.
To identify candidate substrates of Rkm1, we first remove proteins that are not strongly enriched by 3xMBT over 3xMBT D355N , in this case requiring a ratio greater than 2 averaged between the two replicates. We also calculate the wild-type over knockout ratio from the two experiments with label-swap and visualize the results as a scatter plot (Fig. 3b) . In this case, signal for Rpl23, the best characterized substrate for Rkm1, is noticeably stronger from wild-type cells than rkm1∆ (Fig. 3b,c) . The effect size of about 50% is consistent with the fact that Rpl23 is methylated by both Rkm1 and Rkm2 (ref. 26) . Pull-down of other ribosomal proteins is not similarly disrupted in the rkm1∆ cell sample, probably because ribosomal proteins are not an intact complex after high-salt extraction in the sample preparation and overnight pull-down.
We also find that the heat-shock protein Ssa4 is strongly enriched by 3xMBT from wild-type cells relative to knockout cells, making it a candidate target for Rkm1. It remains possible that Ssa4 is simply more abundant in wild-type cells or that it is captured through association with Rpl23. This result could be validated by using targeted mass spectrometry to verify that Ssa4 is methylated, and then by performing an in vitro methylation reaction with recombinant Rkm1 and Ssa4.
Data availability
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